Navigation Links
Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Date:6/1/2011

eter, Clinical Trial (5), 2011 106

Table 77: NeuroFlo Catheter, Clinical Trial (6), 2011 107

Table 78: NeuroFlo Catheter, Clinical Trial (7), 2011 108

Table 79: NeuroFlo Catheter, Clinical Trial (8), 2011 109

Table 80: X Calibur Aneurysm Occlusion Device, Product Status, 2011 110

Table 81: X Calibur Aneurysm Occlusion Device, Clinical Trials, 2011 111

Table 82: Neucrylate AN, Product Status, 2011 111

Table 83: Interventional Neurology Market, Deal Value ($m) and Volume, 2004 – 2010 113

1.2 List of Figures

Figure 1: Interventional Neurology, Market Segmentation 10

Figure 2: Embolization Coils Procedure 11

Figure 3: Aneurysm Clipping Procedure 12

Figure 4: Types of Cerebral Aneurysms 13

Figure 5: Cerebral Aneurysm, Pathophysiology 14

Figure 6: Cerebral Aneurysm, Disease Burden, 2008 15

Figure 7: Interventional Neurology Market, Global, Revenue ($m), 2003-2010 16

Figure 8: Interventional Neurology Market, Global, Revenue ($m), 2010-2017 17

Figure 9: Interventional Neurology Treatment, by Disease 18

Figure 10: Interventional Neurology, Market Dynamics 21

Figure 11: Embolic Systems Market, Global, Revenue ($m), 2003-2010 25

Figure 12: Embolic Systems Market, Global, Revenue ($m), 2010-2017 26

Figure 13: Navigational Systems Market, Global, Revenue ($m), 2003-2010 28

Figure 14: Navigational Systems Market, Global, Revenue ($m), 2010-2017 29

Figure 15: Neurovascular Stents Market, Revenue ($m), 2003-2010 31

Figure 16: Neurovascular Stents Market, Revenue ($m), 2010-2017 32

Figure 17: Aneurysm Clips Market, Global, Revenue ($m), 2003-2010 34

Figure 18: Aneurysm Clips Market, Global, Revenue ($m), 2010-2017 35

Figure 19: Interventional Neurology Market, The US, Revenue ($m), 2003-2010 37

Figure 20: Interventional Neurology Market, The US, Revenue ($m), 2010-2017 38


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Reportlinker Adds Chinas Guidebook for Pharmaceutical Patent Protection
2. Reportlinker Adds Greece Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017
3. Reportlinker Adds Global Top 10 Pharmaceutical Companies: Industry, Financial and SWOT Analysis
4. Reportlinker Adds the Future of In Vitro and In Vivo Diagnostic Integration
5. Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018
6. Reportlinker Adds Epidemiology: Major Abdominal Surgery - A key risk factor for deep vein thrombosis and pulmonary embolism
7. Reportlinker Adds The Antibacterials Market Outlook to 2016
8. Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015
9. Reportlinker Adds The Drug-Eluting Stent Market Outlook to 2016
10. Reportlinker Adds The Infusion Pump Market Outlook to 2016
11. Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Calif. , Sept. 17, 2014 ... Prostate Vanguard, an awareness campaign to educate men about ... needle biopsies of the prostate. Annually, a million ... gland through the rectum. Multi-parametric MRI (MP-MRI) of the ... prostate cancer (CSPC). Men need to be fully ...
(Date:9/17/2014)... OTEMR, Inc. , ONETOUCH EMR, 2.0 has achieved ONC ... the software is capable of supporting eligible providers with ... measures required to qualify for funding under the American ... certified on July 14, 2014 by ICSA Labs ... (ONC-ACB) and is compliant in accordance with applicable criteria ...
(Date:9/17/2014)... Sept. 17, 2014  Members of the physician ... Associates announced today that the enterprise is ... its image sharing capabilities and provide immediate cluster ... failures. In addition, the Dicom Systems enterprise imaging ... PACS systems to more effectively deliver the right ...
Breaking Medicine Technology:Prostate Cancer Awareness Month - Stop Random Biopsies 2Prostate Cancer Awareness Month - Stop Random Biopsies 3OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 2OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 3Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 2Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 3
... 4 NovaRx Corporation announced today the appointment of ... and Chief Operating Officer. Dr. Russell brings to ... discovery and a long history of success driving innovation ... experience leading entrepreneurial biotechnology companies developing pioneering new technologies. ...
... - Tasigna front-line data demonstrating potential in newly diagnosed patients with ... sessions at ASH , , - ... by significantly reducing toxic iron that can damage key organs , ... major independent breast cancer trial at SABCS to report on optimal ...
Cached Medicine Technology:NovaRx Appoints Industry Veteran as President and COO 2NovaRx Appoints Industry Veteran as President and COO 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 5More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 6More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 7More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 8More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 9More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 10More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 11More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 12More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 13More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 14More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 15More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 16More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 17More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 18More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 19More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 20More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 21More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 22
(Date:9/17/2014)... Final Cut Pro X plugin developers have announced a new ... , “ProBlue 5k is a compilation of anamorphic flares that ... Christina Austin, CEO of Pixel Film Studios. “Blurring the line ... changer.” , ProBlue 5k is the ultimate Ultra High Definition ... footage compilation of over 100 anamorphic flares can be applied ...
(Date:9/17/2014)... Las Vegas, NV (PRWEB) September 17, 2014 ... by Dr. Dan Ritchie and Dr. Cody Sipe that is ... quality of life and longevity has caught the attention of ... ask most people in their 50s, 60s, or even 70s ... quality of life on a day-to-day basis, they would probably ...
(Date:9/17/2014)... the ends of chromosomes could hold the key to a ... skin cancer according to new research from the University ... new genetic risk factor for melanoma. , It is well ... of those most at risk of developing melanoma. For example, ... they burn more easily. , It now appears that another ...
(Date:9/17/2014)... In Pretrial Order #139 (Scheduling of Discovery ... would be beneficial in this [MDL].” Accordingly, the court ... end of December,” the order further provides, “the court ... , “The plain import of this order is ... to be discussed as these cases progress toward trial,” ...
(Date:9/17/2014)... blood test that measures DNA from a prostate cancer ... the state of a man,s disease, a new study ... could reveal when treatment for advanced prostate cancer ... researchers suggested. "Our study showed that a steroid ... often initially very effective started to activate harmful mutations ...
Breaking Medicine News(10 mins):Health News:A New Plugin Entitled ProBlue 5k Was Released Today from Pixel Film Studios Exclusively for Final Cut Pro X 2Health News:Functional Fitness Solution: Review Exposes Dr. Dan Ritchie and Dr. Cody Sipe’s Guide to Everyday Fitness for Longevity 2Health News:Chromosome buffers hold key to better melanoma understanding 2Health News:Transvaginal Mesh Lawsuit News: New Order in C.R. Bard MDL Sets Schedule of Conferences for September to December, the Rottenstein Law Group LLP Reports 2Health News:DNA Blood Test Might Identify Status of Prostate Cancer 2
... SAGE Launch Clinical Psychological Science ,Association for Psychological ... Angeles, CA (April 23, 2012) The Association for ... Clinical Psychological Science , a new peer-reviewed journal focused ... venue for cutting-edge research across a wide range of ...
... Guy, M.D., professor of ophthalmology at Bascom Palmer Eye ... Medicine, has pioneered a novel technological treatment for Leber ... causes rapid, permanent, and bilateral loss of vision in ... Genetic mutations in the mitochondria (part of the ...
... 23 (HealthDay News) -- Teen drivers and passengers are more likely ... belt laws, often promoted as "click it or ticket" laws, a ... and ticket drivers solely for not wearing a seat belt. Under ... are stopped for other reasons, such as speeding. Primary seat ...
... The Global Cardiovascular Disease Taskforce called on the 11,000 ... cardiovascular disease (CVD) community at large, to support the ... disease (NCD) mortality by 25 per cent by 2025. ... from the world,s largest CVD organizations including the American ...
... Hispanic lung cancer patients seem to live longer than ... Cancer , a peer-reviewed journal of the American Cancer ... types of cancer, certain yet-to-be-defined genetic and/or environmental factors ... studies that look at ethnic and racial disparities in ...
... Health (NIH) scientists and their colleagues in China have ... called sasX , which plays a pivotal role ... in most of Asia. Senior author Michael Otto, Ph.D., ... says these findings illustrate at the molecular level how ...
Cached Medicine News:Health News:Association for Psychological Science, SAGE launch Clinical Psychological Science 2Health News:Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder 2Health News:Stricter Seat Belt Laws Get Teens to Buckle Up, Study Shows 2Health News:Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology 2Health News:Hispanic lung cancer patients tend to live longer than blacks and whites 2Health News:NIH scientists link quickly spreading gene to Asian MRSA epidemic 2
Tracheal Suction Latex Rubber Catheters - Funnel End...
Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip....
KCIs KinAir IV combines Advanced Pressure Relief Therapy with a manual wound care turn to provide optimum skin care and patient,positioning....
... The Paradigm LD400 FT is an affordable ... exam time by at least 40%. It has ... It features rapid setup and easy two-button operation ... friendly. The LD 400 FT is the workhorse ...
Medicine Products: